Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Renault

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
European Journal of Medicinal Chemistry|December 26, 2018
Benzo[d]thiazol-2(3H)-ones as new potent selective CB<sub>2</sub> agonists with anti-inflammatory propertiesNatascha Leleu-Chavain, Davy Baudelet, Valéria Moas Heloire, et al.
Journal of Medicinal Chemistry|August 19, 2016
Synthesis and Biological Evaluation of N-[2-(4-Hydroxyphenylamino)-pyridin-3-yl]-4-methoxy-benzenesulfonamide (ABT-751) Tricyclic Analogues as Antimitotic and Antivascular Agents with Potent in Vivo Antitumor ActivityZacharie Segaoula, Julien Leclercq, Valérie Verones, et al.
Bioorganic & Medicinal Chemistry|May 27, 2011
New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitisVirginie Andrzejak, Giulio G Muccioli, Mathilde Body-Malapel, et al.
Gene|August 9, 2011
Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French populationChristian L Lino Cardenas, Nicolas Renault, Amaury Farce, et al.
European Journal of Medicinal Chemistry|February 8, 2008
Homology modeling of MT1 and MT2 receptorsAmaury Farce, Anton O Chugunov, Cédric Logé, et al.
British Journal of Pharmacology|September 13, 2017
Importance of the second extracellular loop for melatonin MT<sub>1</sub> receptor function and absence of melatonin binding in GPR50Nathalie Clement, Nicolas Renault, Jean-Luc Guillaume, et al.
Journal of Medicinal Chemistry|October 29, 2010
4-Oxo-1,4-dihydropyridines as selective CB2 cannabinoid receptor ligands: structural insights into the design of a novel inverse agonist seriesJamal El Bakali, Giulio G Muccioli, Nicolas Renault, et al.
European Journal of Medicinal Chemistry|October 30, 2015
Design and synthesis of fused tetrahydroisoquinoline-iminoimidazolinesValeria Moas-Héloire, Nicolas Renault, Vania Batalha, et al.
ACS Medicinal Chemistry Letters|February 21, 2015
Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against ColitisJamal El Bakali, Giulio G Muccioli, Mathilde Body-Malapel, et al.
European Journal of Immunology|December 10, 2008
Genetic, molecular and functional analyses of complement factor I deficiencySara C Nilsson, Leendert A Trouw, Nicolas Renault, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
European Journal of Medicinal Chemistry|December 26, 2018
Benzo[d]thiazol-2(3H)-ones as new potent selective CB<sub>2</sub> agonists with anti-inflammatory propertiesNatascha Leleu-Chavain, Davy Baudelet, Valéria Moas Heloire, et al.
Journal of Medicinal Chemistry|August 19, 2016
Synthesis and Biological Evaluation of N-[2-(4-Hydroxyphenylamino)-pyridin-3-yl]-4-methoxy-benzenesulfonamide (ABT-751) Tricyclic Analogues as Antimitotic and Antivascular Agents with Potent in Vivo Antitumor ActivityZacharie Segaoula, Julien Leclercq, Valérie Verones, et al.
Bioorganic & Medicinal Chemistry|May 27, 2011
New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitisVirginie Andrzejak, Giulio G Muccioli, Mathilde Body-Malapel, et al.
Gene|August 9, 2011
Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French populationChristian L Lino Cardenas, Nicolas Renault, Amaury Farce, et al.
European Journal of Medicinal Chemistry|February 8, 2008
Homology modeling of MT1 and MT2 receptorsAmaury Farce, Anton O Chugunov, Cédric Logé, et al.
British Journal of Pharmacology|September 13, 2017
Importance of the second extracellular loop for melatonin MT<sub>1</sub> receptor function and absence of melatonin binding in GPR50Nathalie Clement, Nicolas Renault, Jean-Luc Guillaume, et al.
Journal of Medicinal Chemistry|October 29, 2010
4-Oxo-1,4-dihydropyridines as selective CB2 cannabinoid receptor ligands: structural insights into the design of a novel inverse agonist seriesJamal El Bakali, Giulio G Muccioli, Nicolas Renault, et al.
European Journal of Medicinal Chemistry|October 30, 2015
Design and synthesis of fused tetrahydroisoquinoline-iminoimidazolinesValeria Moas-Héloire, Nicolas Renault, Vania Batalha, et al.
ACS Medicinal Chemistry Letters|February 21, 2015
Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against ColitisJamal El Bakali, Giulio G Muccioli, Mathilde Body-Malapel, et al.
European Journal of Immunology|December 10, 2008
Genetic, molecular and functional analyses of complement factor I deficiencySara C Nilsson, Leendert A Trouw, Nicolas Renault, et al.
Pageof 5